Retrospective study of 30 cases of Legionella pneumonia in the Kansai region

J Infect Chemother. 2006 Oct;12(5):272-6. doi: 10.1007/s10156-006-0463-x. Epub 2006 Nov 6.

Abstract

Thirty Legionella pneumonia cases were clinically investigated retrospectively from 1999 to 2005 at the Respiratory Medicine Department of Kyoto University and affiliated hospitals. Twenty-eight cases were sporadic and two cases were part of an outbreak. The patients consisted of 28 men and 2 women, with a mean age of 58.8 years (range 25-87). Nineteen cases were smokers and 19 had some underlying disease. The mean period from the disease occurrence to presenting at a hospital was 4.8 days (range 1-15). The mean period from presenting at hospital to Legionella pneumonia diagnosis was 4.6 days (range 0-22). Urinary antigen detection tests for Legionella pneumophilla were performed for 25 cases, and resulted in the diagnosis of 22 cases. Other diagnostic tests with positive findings were culture (buffered charcoal-yeast extract agar, BCYE), the polymerase chain reaction (PCR) test, and serological diagnosis (enzyme immunoassay and microagglutination test). Legionella species diagnosis was obtained by culture and serology for 13 cases: 10 cases had Legionella pneumophila serogroup 1, 2 cases had Legionella pneumophila serogroup 6, and 1 case had Legionella longbeachea. Fluoloquinolones (Fq) are most often used for therapy, especially in recent cases, and were predominantly the chosen treatment (70%). Death due to Legionella pneumonia occurred in 4 cases: 3 cases had severe underlying diseases, and 1 case took 18 days to diagnose (doctors' delay). To detect the majority of Legionella pneumonia cases, a combination of diagnostic examinations is still needed. Regarding the management of community-acquired pneumonia, both the cost and the indication of diagnostic examinations for Legionella infection should be considered simultaneously.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Infective Agents / therapeutic use
  • Female
  • Fluoroquinolones / therapeutic use
  • Humans
  • Japan / epidemiology
  • Legionella longbeachae / isolation & purification*
  • Legionella pneumophila / isolation & purification*
  • Legionellosis / drug therapy
  • Legionellosis / epidemiology*
  • Legionellosis / microbiology
  • Legionnaires' Disease / drug therapy
  • Legionnaires' Disease / epidemiology*
  • Legionnaires' Disease / microbiology
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Anti-Infective Agents
  • Fluoroquinolones